OOIR: Observatory of International Research

Papers

(The H4-Index of Gut Microbes is 41. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-02-01 to 2025-02-01.)

Article	Citations
Technical versus biological variability in a synthetic human gut community	161
Limosilactobacillus reuteri - a probiotic gut commensal with contextual impact on immunity	139
Limosilactobacillus reuteri DS0384 promotes intestinal epithelial maturation via the postbiotic effect in human intestinal organoids and infant mice	139
Epidemiological and microbiome associations of Clostridioides difficile carriage in infancy and early childhood	115
Meta-analysis reveals Helicobacter pylori mutual exclusivity and reproducible gastric microbiome alterations during gastric carcinoma progression	114
Interlink between the gut microbiota and inflammation in the context of oxidative stress in Alzheimer’s disease progression	110
Unveiling Candida albicans intestinal carriage in healthy volunteers: the role of micro- and mycobiota, diet, host genetics and immune response	81
Methodological challenges in neonatal microbiome research	77
EspH interacts with the host active Bcr related (ABR) protein to suppress RhoGTPases	76
Detecting host responses to microbial stimulation using primary epithelial organoids	75
A foundational approach to culture and analyze malnourished organoids	66
Oxygen concentration modulates colibactin production	63
Unique Pakistani gut microbiota highlights population-specific microbiota signatures of type 2 diabetes mellitus	61
Modeling spatial interaction networks of the gut microbiota	60
Interactions and substrate selectivity within the SctRST complex of the type III secretion system of enteropathogenic Escherichia coli	59
The development of live biotherapeutics against Clostridioides difficile infection towards reconstituting gut microbiota	58
Gut microbiota composition as a candidate risk factor for dimethyl fumarate-induced lymphopenia in multiple sclerosis	57
Intestinal microbiota modulates pancreatic carcinogenesis through intratumoral natural killer cells	56
Children and adolescents with attention deficit hyperactivity disorder and autism spectrum disorder share distinct microbiota compositions	55
Functional effects of human milk oligosaccharides (HMOs)	53
MlrA, a MerR family regulator in Vibrio cholerae , senses the anaerobic signal in the small intestine of the host to promote bacterial intestinal colonization	52
Multiomic spatial analysis reveals a distinct mucosa-associated virome	51
Gut microbiota-motility interregulation: insights from in vivo, ex vivo and in silico studies	49
In vitro adhesion, pilus expression, and in vivo amelioration of antibiotic-induced microbiota disturbance by Bifidobacterium	49
Fiber mixture-specific effect on distal colonic fermentation and metabolic health in lean but not in prediabetic men	49

E. coli Common pili promote the fitness and virulence of a hybrid aEPEC/ExPEC strain within diverse host environments	49
L. rhamnosus CNCM I-3690 survival, adaptation, and small bowel microbiome impact in human	48
Prolonged oral antimicrobial administration prevents doxorubicin-induced loss of active intestinal stem cells	48
The human gut serves as a reservoir of hypervirulent Klebsiella pneumoniae	48
Host-mycobiome metabolic interactions in health and disease	47
Microbial-host-isozyme: unveiling a new era in microbiome–host interaction	47
Campylobacter jejuni benefits from the bile salt deoxycholate under low-oxygen condition in a PldA dependent manner	47
Lactobacillus johnsonii N6.2 phospholipids induce immature-like dendritic cells with a migratory-regulatory-like transcriptional signature	45
Dynamic associations between the respiratory tract and gut antibiotic resistome of patients with COVID-19 and its prediction power for disease severity	44
Escherichia coli triggers α-synuclein pathology in the LRRK2 transgenic mouse model of PD	44
Myeloid-derived suppressor cells prevent disruption of the gut barrier, preserve microbiota composition, and potentiate immunoregulatory pathways in a rat model of experimental autoimmune encephalomye	43
Dietary fiber-based regulation of bile salt hydrolase activity in the gut microbiota and its relevance to human disease	42
Loss-of-function SLC30A2 mutants are associated with gut dysbiosis and alterations in intestinal gene expression in preterm infants	42
Compensatory intestinal antibody response against pro-inflammatory microbiota after bariatric surgery	42
Gut microbiota: a non-target victim of pesticide-induced toxicity	41
Microbial bile salt hydrolase activity influences gene expression profiles and gastrointestinal maturation in infant mice	41
Salmonella enterica subsp. II serovar 4,5,12:a:- may cause gastroenteritis infections in humans	41